Registry of catheter interventions for pulmonary embolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data from patients with moderate to high-risk pulmonary embolism who are treated with invasive catheter interventions. It includes both retrospective cases from 2014 and prospective cases starting from 2018. The aim is to evaluate the safety and effectiveness of various percutaneous interventions for acute pulmonary embolism based on established guidelines. By analyzing these cases, the study seeks to improve understanding of acute management strategies for this serious condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adult patients (aged 18 years old or older)
* confirmed diagnosis of acute PE (on computed tomography or echocardiogram plus pulmonary angiography)
* high-risk PE or intermediate-high risk according to ESC risk stratification in the 2019 guidelines (briefly, elevated cardiac biomarkers \[troponin or N-terminal pro-B-type natriuretic peptide\], and right ventricle to left ventricle ratio \> 0.9 \[on computed tomography or echocardiogram\], and PE severity index III to IV or simplified PE severity index=1
* eligibility for catheter-directed intervention

Exclusion Criteria:

* unconfirmed diagnosis of PE
* undefined risk stratification, and
* PE with uncertain chronology or beyond seven days of symptom initiation.

Where it's running

• Hospital Clinico San Carlos
  Madrid, Madrid, Spain Recruiting

Study contacts

• Study coordinator: Pablo Salinas, MD, PhD
• Email: salinas.pablo@gmail.com
• Phone: +34 913303000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing catheter-based treatments for acute pulmonary embolism

  This registry compares outcomes of different catheter-based therapies to see which works best and is safest for people hospitalized with acute pulmonary embolism.

  Recruiting Chinese University of Hong Kong · Hong Kong, Hong Kong · NCT07029841

• Chair lift test to predict outcomes after non-severe pulmonary embolism

  We will test whether a chair lift test can help predict short-term outcomes for hospitalized adults with non-severe pulmonary embolism.

  Recruiting University Hospital, Rouen · Rouen · NCT06166329

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Pulsatile Electrical Impedance Tomography to Diagnose and Monitor Acute Pulmonary Embolism

  This study tests whether bedside pulsatile electrical impedance tomography can help diagnose and track acute pulmonary embolism without radiation.

  Recruiting Beijing Tsinghua Chang Gung Hospital · Beijing, Beijing Municipality and 3 other locations · NCT07724197

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.